Healthcare Institute of New Jersey Announces Management Changes
Jul 8 14
The HealthCare Institute of New Jersey (HINJ) has announced new officers of its Board of Trustees as well as the leadership of its Steering Committee. Craig B. Bleifer, Vice President, General Counsel and Secretary, Daiichi Sankyo Inc., has been named as Chair of the HINJ Board of Trustees. Mr. Bleifer, who previously served as a Vice Chair of the HINJ Board, is responsible for the oversight of Daiichi Sankyo's Legal Affairs, Intellectual Property, Commercial Regulatory Affairs, Government Affairs and Public Policy, and Public Affairs departments. Mr. Bleifer and his team support commercial, clinical and corporate activities in the U.S. and globally. Mr. Bleifer succeeds Kevin T. Rigby, U.S. Country Head Public Affairs, Vice President Public Affairs, Novartis Pharmaceuticals Corporation. Mr. Rigby will continue to serve on the Board. At its June 13 meeting, the HINJ Board elected two new Vice Chairs: Yin C. Becker, Vice President, Communications, Public Affairs and Strategic Marketing, Stryker. Raymond Sacchetti, Senior Vice President, U.S. Access and Government Affairs, Bristol-Myers Squibb Company. In addition, Jeffrey S. Sherman, Senior Vice President and General Counsel, BD, continues to serve as Treasurer, and Lisa M. Goldman, Executive Director, U.S. Oncology Ethics and Compliance, Novartis Pharmaceuticals Corporation, continues to serve as Board Secretary. HINJ also announced that Wendy M. Lazarus, Director, Government Relations and Public Affairs, Pfizer Inc., is the new Chair of HINJ's Steering Committee. Ms. Lazarus, who has served as Vice Chair, succeeds Sarah G. Kan, Associate Director, State and External Affairs, Novartis Pharmaceuticals Corporation.